Total Funding
38
Total FundingSeed raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
150697
Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.
Michael Smith: Co-Founder and Chief Executive Officer
Edwin Urrutia: Co-Founder
About the Company
Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics. Its business strategy is focused on targeting high-value solid oral, sterile injectable, and alternative dosage form ANDAs that are difficult to develop and that bring sustainable profitability.
